Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COP9 signalosome subunit 4 (COPS4, also known as CSN4 or SGN4) is a highly conserved protein that is one of eight core subunits of the COP9 signalosome complex—a major regulatory complex structurally and functionally similar to the 19S regulatory particle of the 26S proteasome[1][5]. The COP9 signalosome regulates the activity and remodeling of cullin–RING ubiquitin ligases (CRLs) via deneddylation, thereby influencing the stability and degradation of numerous cellular proteins involved in processes such as cell cycle regulation, DNA repair, apoptosis, and signal transduction[2][4][1]. COPS4 specifically contributes to the assembly and stability of the COP9 signalosome and mediates key protein–protein interactions required for the complex’s regulatory function[2][3]. Dysregulation or altered expression of COPS4/CSN4 can impact cancer progression, neurodevelopmental and neurodegenerative disorders, and DNA repair syndromes by disrupting the ubiquitin–proteasome system and associated signaling networks[1][2]. No specific drugs target COPS4 directly, and as an essential scaffolding subunit, it is not generally considered a direct therapeutic target[2][1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COP9 signalosome subunit 4 (COPS4).